Mike Darcey is to leave BSkyB to take Tom Mockridge’s role as CEO of News International as part of the restructuring of News Corp into two companies looking after publishing and media and entertainment respectively.News Corp has also confirmed that Robert Thomson, the managing editor of the Wall Street Journal, will become the CEO of the new publishing entity, to be called News Corp, while Rupert Murdoch will serve as chairman and CEO of Fox Group, the umbrella group for film and TV activities, and chairman of News Corp. Chase Carey will serve as president and chief operating officer of Fox Group, while James Murdoch will continue as deputy chief operating officer.Darcey has been chief operating officer at BSkyB since 2006. “I’m delighted that Mike Darcey has agreed to take the reins as News International’s new CEO,” said Rupert Murdoch. “Mike is a world-class executive with unprecedented strategic and commercial experience and I look forward to benefiting from his many talents. His broadcasting background will provide important leadership in the development of our already impressive suite of digital products at News International.”News Corp expects to complete the split by the middle of next year, pending approval of the board and shareholders, as well as regulatory approvals, favourable rulings from certain tax jurisdictions on the tax-free nature of the transaction to the company and its stockholders, and certain other conditions. News Corp expects to make preliminary filings with the SEC on the separation shortly.Bedi Ajay Singh, the former finance chief at MGM Studios, will become chief financial officer of News Corp. Paul Cheesbrough, News Corp’s chief technology officer and a former digital media chief at the BBC, will continue in his role for the publishing company.“This is an incredibly exciting time, for me personally, and for our companies’ ambitious futures,” said Murdoch. “The challenges we face in the publishing and media industries are great, but the opportunities are greater.”
Canal+’s OTT TV service myCanal has teamed up with Apple to offer 4K UHD TV content on the new Apple TV 4K box.My Canal subscribers with a n Apple 4K UHD box will be able to view the best Ligue 1 football match of the day in 4K UHD, along with original Canal+ series and selected movies, series and documentaries in 4K UHD.Content on the service in the format will include the latest seasons of originals Le Bureau des Légends and Kaboul Kitchen, with others including Versailles, The Young Pope, Jour Polaire and Les Guerriers de l’Ombre to be added on an ongoing basis.In order to view the content, subscriber will need the Apple box, a 4K TV and an internet connection of 20Mbps or above.Canal+ said that 4K UHD content on the myCanal service would be made available on other Apple devices including iPads, MacBooks and iMacs soon.The pay TV operator has teamed up with French technology outfits Ateme and Anevia to tap into their expertise in securing and distributing 4K UHD content both live and on-demand.
Digital Element’s Charlie Johnson.Charlie Johnson, digital media director of Europe for Digital Element discusses using IP Intelligence data to manage digital rights and improve user experience.A quarter of internet consumers in Europe are being blocked from routine online activities, including streaming media and uploading content to popular social network sites, according to a recent Eurobarometer survey. Additionally, the survey found that a large proportion of browsers (41% of mobile and 37% of fixed line) experience problems viewing video content due to connection speed issues.These types of negative online experiences can frustrate users, are damaging for brands, and in the majority of cases are unnecessary. There is an alternative. By using IP Intelligence data, content providers can stream media to the right visitors at the right speed, enhance the customer experience, increase customer loyalty, and comply with geographic content rights.IP Intelligence is information returned from a user’s IP address – information such as location, connection speed and ISP. With this information, websites can make decisions about what content to make available to web visitors. However, it is important to work with accurate data, and not all IP data providers are created equal. There is a vast chasm between those who simply repackage publicly-available data and premium providers who deploy multiple methodologies to analyse IP routing infrastructure.Premium IP data, at its most granular level, can enable websites to accurately locate a user down to the city/postal code sector level without becoming personally-identifiable. The coverage is global, accuracy is 99.99% at a country level, and the data is refreshed regularly. It is an effective business solution that is simple to integrate into content streaming platforms and manage in-house. Conversely, publically-available data has patchy global coverage, is rarely updated, and is inherently inaccurate.It is vital for content providers to comply with digital rights licenses, either at a country or regional level, and yet many are using poor approaches that restrict content to users who should be able to view, while allowing access to those who should not. The deployment of accurate IP technology negates this issue because it accurately identifies the user’s location. At the same time, working with less accurate data providers can create false restrictions, leading to disgruntled consumers, as the Eurobarometer survey intimates.Furthermore, accurate IP-derived connection speed data helps ensure streaming content is optimised to the viewing platform and helps eliminate the technical problems associated with delivering video or music over a range of devices and connectivity types.To summarise, content owners can optimise the web media viewing experience and reduce negative online experiences by deploying the following IP-derived data parameters:Geolocation Accurately locating web visitors down to postal code sector/zip level enables delivery of localised content and eradicates false positives while maintaining geographic rights compliance with content owners. Accuracy can only be achieved by using accredited IP data specialists monitoring the constantly changing public internet 24/7.Connection speedThe web viewing experience can also be enhanced by optimising the content format according to the user’s connection speed and type, seamlessly providing a positive brand experience and reducing abandonment from poorly-displayed content.ProxiesContent owners also need to protect themselves from those actively falsifying their location, but not to the detriment of other legitimate users. Proxy IPs can fluctuate within a day, and therefore daily and weekly updates to this data is necessary to minimise the risk of false positives.MobileBeing able to recognise the device type and/or connection type is important to optimise content delivery. Distinguishing between WiFi, fixed internet, 3G and 4G can enhance a user’s viewing experience and generate additional revenue channels while maintaining consumer loyalty.As Europe continues to move towards an “open internet”, website and content owners need to continue to embrace IP data targeting to connect and enhance users’ online viewing experiences, whilst remaining focused on compliance and rights management. Simple, cost-effective and intelligent IP targeting is an integral component of a geographic rights management solution that protects online content owners while also building strong consumer relationships.For more information visit info.digitalelement.com/uk[advert_ banner]
Reviewed by James Ives, M.Psych. (Editor)Dec 6 2018Children’s Hospital of Philadelphia (CHOP) celebrates a pivotal moment in medicine: approval by the European Commission (EC) of LUXTURNA® (voretigene neparvovec), the first and only gene therapy for patients with an inherited retinal disease, last month. This also makes LUXTURNA the first gene therapy for a genetic disease that has received regulatory approval in both the U.S. and European Union (EU).The EC approved LUXTURNA, a one-time gene therapy for the treatment of vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations, in pediatric and adult patients who have sufficient viable retinal cells. RPE65 -mediated inherited retinal disease is a progressive condition that leads to total blindness in most patients.The authorization is valid in all 28 member states of the EU, as well as Iceland, Liechtenstein and Norway. In December 2017, the U.S. Food and Drug Administration (FDA) approved LUXTURNA for use in patients in the U.S.”The European Commission’s approval of LUXTURNA highlights the vital role of pediatric research in developing breakthrough cures,” said Bryan Wolf, MD, PhD, Chief Scientific Officer and Chair of the Department of Biomedical and Health Informatics at Children’s Hospital of Philadelphia. “The research conducted as a collaborative effort between CHOP’s Raymond G. Perelman Center for Cellular and Molecular Therapeutics (CCMT) and investigators at the Perelman School of Medicine at the University of Pennsylvania laid the groundwork for this revolutionary gene therapy, which was developed and is now manufactured by Spark Therapeutics. Today, we are thrilled to see LUXTURNA approved as a therapy for children and adults outside the U.S.”Related StoriesGuidelines to help children develop healthy habits early in lifeResearchers identify gene mutations linked to leukemia in children with Down’s syndromeRevolutionary gene replacement surgery restores vision in patients with retinal degenerationCHOP founded Spark Therapeutics in 2013 in an effort to accelerate the timeline for bringing new gene therapies to market. Spark’s mission, to create a world where no life is limited by genetic disease, was to build on the foundational research conducted over a multi-year period by the CHOP and Penn Medicine teams.Beginning in 2000, the initial research for LUXTURNA was conducted by Jean Bennett, MD, PhD, F.M. Kirby professor of Ophthalmology at the Perelman School of Medicine at the University of Pennsylvania’s Scheie Eye Institute, and Albert M. Maguire, MD, a professor of Ophthalmology at Penn’s Perelman School of Medicine and an attending physician at CHOP. Bennett and Maguire joined forces with then-CHOP researcher Katherine A. High, MD, a gene therapy pioneer who directed the CCMT and who is now Spark’s President and head of research and development. Dr. Maguire served as a Principal Investigator of the therapy’s clinical trials.In the U.S., the gene therapy is currently administered at 10 treatment centers by leading retinal surgeons who receive training provided by Spark Therapeutics on the administration procedure.In January 2018, Spark Therapeutics entered into a licensing and supply agreement with Novartis covering development, registration and commercialization rights to LUXTURNA in markets outside the U.S. Upon the transfer of the marketing authorization from Spark Therapeutics to Novartis. Novartis can commercialize LUXTURNA in the EU/EEA. Novartis already has exclusive rights to pursue development, registration and commercialization in all other countries outside the U.S., and Spark Therapeutics will supply the gene therapy to Novartis.Source: https://www.chop.edu/news/children-s-hospital-celebrates-european-commission-approval-first-its-kind-gene-therapy
The study from Western Sydney University, looked at 16 clinical trials that analyzed 45,826 people who had modified their diets to alleviate their symptoms of depression and anxiety. The clinical trials were from a more than one nation including Australia, Brazil, Canada, Italy and the UK. Lead researcher Dr Joseph Firth from Western Sydney University said that the major change that their diets involved was reducing “junk food intake” and replacing high fat and high sugar foods with foods that are rich in nutrients and fibres such as fruits and vegetables. Dr Firth said, “We took a bit of a close look at the data and interestingly found there was no significant differences in the types of diets used… Weight loss diets were just as effective as nutrient boosting diets.” This means that no “extreme diets” are necessary for depression, he explained. What is needed is a change in the basics he said. Dr. Firth added that the study did not find a beneficial effect of diets on anxiety disorders and women with depression were found to benefit more with an altered diet than men.Related StoriesSome children are at greater risk of ongoing depression long after being bulliedNew structured approach to managing patients with depression in primary careStudy reveals link between inflammatory diet and colorectal cancer riskDr. Firth said that there have been studies showing that regular exercise can have a protective effect against depression. This is the first study to prove that a healthy diet can also play a role in reducing the symptoms of depression. He explained that an average Australian individual consumes around 19 servings of junk food per week and much less amount of the recommended fruits, vegetables and whole grains that are rich in nutrients and fibre.The authors emphasize that diet is not a replacement to tested and accepted treatments of depressive illness including medications and psychotherapy. However diets can be an additional remedy they said. They call for public health campaigns to emphasize upon healthy diet and its effects on the mental health. “Public health schemes are trying to improve people’s diets and looking at the physical health outcomes… and focusing on combating things like obesity… They should also pay attention to actual positive mental health outcomes that could occur and improve people’s diets on a large scale to fix people’s psychological well being,” Dr. Firth said.“Thus, depressive disorders incur considerable burden not only for individuals, but also for society due to the high economic cost from lost productivity and demand on healthcare services,” The authors write. Authors add that dietary interventions could be a “novel” approach to depression and conclude, “Future research is required to determine the specific components of dietary interventions that improve mental health, explore underlying mechanisms, and establish effective schemes for delivering these interventions in clinical and public health settings.”In 2017 and 2018, there has been a rise in depressive illness with at least one in five Australian experiencing a mental illness (13.1 per cent had anxiety and 10.4 per cent felt depressed). Women were more vulnerable than men, say reports. A healthy balanced diet. Image Credit: Syda Productions / Shutterstock By Dr. Ananya Mandal, MDFeb 5 2019It has been speculated earlier that a healthy diet can raise the mood and reduce symptoms of mild depression. A new study proves the cause and effect of healthy diet and improved symptoms of depression.The results of the new study titled, “The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials,” was published this week in the latest issue of the journal Psychosomatic Medicine. Source:https://insights.ovid.com/crossref?an=00006842-900000000-98656
Related StoriesSchwann cells capable of generating protective myelin over nerves finds researchTargeted treatment offers symptom relief for patients with psychosisStudy: Treatment of psychosis can be targeted to specific genetic mutationBecause the gift is endowed, the perpetual funding will secure the future of behavioral health research at Vanderbilt.”We are already providing clinical care to many patients during their first episode of psychosis. This transformational gift now allows us to map the trajectory of psychosis,” said Stephan Heckers, MD, MSc, chair of the Department of Psychiatry and Behavioral Sciences. “The outstanding translational research environment at Vanderbilt University Medical Center is the ideal place to realize the vision of our donor.”The gift will allow researchers to engage and track patients for longer periods of time, enabling longitudinal research studies that could otherwise not be accomplished. Through enhanced assessments, increased medication monitoring and earlier interventions, the team at Vanderbilt hopes to gain insight into what determines positive and negative treatment outcomes and to extend the lives of people with psychotic disorders, which are associated with a shortened life expectancy.”We are extremely grateful to the donor for making this translational research possible. The donor’s vision will impact many patients at Vanderbilt and will greatly advance our research agenda,” said Heckers. Reviewed by Kate Anderton, B.Sc. (Editor)Jun 13 2019Vanderbilt University Medical Center’s Department of Psychiatry and Behavioral Sciences has received a $10 million endowed gift to fund translational research, support clinical programs and create an endowed chair within the department.As a family member of a loved one with schizophrenia, the donor, who wishes to remain anonymous so the focus remains on the patients and new treatments, is energized by the potential of developing early treatments to slow or prevent psychosis from reaching more critical stages.”Seeing firsthand the devastation of the effects that these diseases have on not just the individual, but the whole family, I believe we need to try anything possible to help alleviate the pain of these experiences,” said the donor. “We keep hoping that something will come along that helps slow the progression of psychotic disorders. If we can work with patients through their first episodes so we can hopefully prevent future ones, that will be the key to improving lives.”The donor made the gift to help other families find answers as they struggle through the challenges of learning a loved one has a psychotic disorder and finding viable treatment options. The early days can be difficult. The burden of psychosis ripples through families as uncertainty and difficulty alter the fabric of life. We are grateful for the pivotal generosity that will ensure other people, and their families, are supported and better understood as they tackle treatment. This gift will reverberate for decades to come.”Jeff Balser, MD, PhD, President and Chief Executive Officer of Vanderbilt University Medical Center and Dean of Vanderbilt University School of Medicine Source:Vanderbilt University Medical Center
Revellers sprint near bulls and steers during the running of the bulls at the San Fermin festival in Pamplona, Spain, July 12, 2019. REUTERS/Susana VeraPAMPLONA, Spain (Reuters) – One man was gored and at least four other people were sent to hospital with injuries following the sixth day of the running of the bulls at the San Fermin festival in the northern Spanish city of Pamplona, the Red Cross said on Friday. Each morning at 8 a.m. (0600 GMT) between July 7 and 14 as part of the week-long festival thousands line the streets of the medieval city to take part in the centuries-old tradition of running with the bulls. In the 875-meter chase through the narrow streets of the city a half dozen, specially bred, aggressive bulls, led by six larger, more docile steers race from their pen to the city’s bull ring as runners dodge horns and stampeding hooves. Friday’s run lasted just two minutes and 18 seconds, though most runners sprint just briefly before being overtaken by the herd. The bulls are later killed in the bull ring by matadors. Reporting by Susana Vera; writing by Paul Day; editing by Jason NeelyOur Standards:The Thomson Reuters Trust Principles.
Defence Minister Nirmala Sitharaman – THE HINDU COMMENTS Defence Minister Nirmala Sitharaman on Tuesday sought to turn the tables around, blaming the previous Congress-led UPA regime for keeping State-run Hindustan Aeronautics Ltd (HAL) out of the Rafale fighter jet deal.The Congress has been accusing the Narendra Modi government of ignoring the public sector unit in the manufacture of the combat aircraft, and favouring the Anil Ambani’s Reliance Defence.Sitharaman claimed the price negotiated for the Rafale by the Modi government was nine per cent cheaper than the UPA deal.“One of the things that did not happen during the UPA was that between Dassault Aviation and HAL they could not agree on production terms. That is why they could not go together. So that speaks for which government failed in terms of getting them together,” said Sitharaman, speaking at an interaction organised by the Indian Women’s Press Corps on Tuesday.Sitharaman was responding to questions based on Congress leader and former defence minister AK Antony’s allegations that if the UPA deal wasn’t cancelled by this government, HAL would’ve acquired the state-of-the-art technology through the transfer of technology and would’ve gained experience to manufacture fighter aircraft.“The previous government could have done anything to strengthen HAL’s offer to ensure that HAL’s terms were appealing enough for Dassault to conclude the deal with it. So the entire issue of HAL not being chosen happened during there time. “You (UPA) have not taken care of HAL. You have not made the terms appealing enough for HAL to bid successfully with Dassault. You have not finalised buying of Rafale aircraft for depleting squadron of IAF,” she said, stressing that questions should be posed to the Congress on HAL.The Congress has accused the Modi government of causing a loss of ₹41,000 crore to the public exchequer by purchasing Rafale aircraft from the French government with the same configuration at thrice the price.Responding to allegations on the pricing front, the Minister said, “We have responded saying your basic price and the basic price that I am getting at, when compared with all the escalation and other things, is 9 per cent cheaper.” Defence Minister claims Modi govt’s procuring the jets 9% cheaper Published on ministers (government) September 18, 2018 COMMENT SHARE SHARE EMAIL SHARE defence